MedTrace Logo

Dilute Bleach Compresses for Radiation Dermatitis

NCT04851522 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2022-02-15

No results posted yet for this study

Summary

This study is looking at the safety of applying dilute bleach compresses to patients receiving radiation therapy and the impact of these dilute bleach compresses on the frequency and severity of skin changes that occur during radiation therapy.

The names of the study interventions involved in this study are:

* Di-Dak-Sol: dilute bleach compresses
* White petrolatum ointment

Conditions

  • Radiation Dermatitis

Interventions

DRUG

Di-Dak-Sol

Topical solution applied externally.

OTHER

White Petrolatum

Topical ointment applied externally

Sponsors & Collaborators

Principal Investigators

  • Jennifer Huang, MD · Boston Children's Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-09
Primary Completion
2022-04-01
Completion
2023-04-01
FDA Drug
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04851522 on ClinicalTrials.gov